Brixton Biosciences wishes to thank our clinical study sites and the research subjects for participating in this ground-breaking clinical trial. We look forward to sharing the data soon!
To evaluate the effectiveness of ReneuRx™ therapy in the treatment of knee osteoarthritis pain in adults aged 22-80 years.2
Participants will attend study visits and complete written or electronic diaries.
Participants will be followed for 6 months after the study treatment.
Study group participants will receive the ReneuRx™ therapy injection around their knee.
Control group participants will receive a steroid injection into their knee joint.
